To test this hypothesis, we investigated the combined effects of RFWD3 inhibition (by shRfwd3 transfection) and an anti‐PD‐L1 antibody (α‐PD‐L1) in LLC tumor‐bearing mice (Figure 6A). This evidence concerns the gene RFWD3 and neoplasm.